InsidersTradesSigma
Follow the Pharmanutra PR - First Sales on the US Market share price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are listed on the IT market, under the oversight of Consob. Operating in the Health Care sector, Pharmanutra PR - First Sales on the US Market has published 1 insider filings. Market capitalisation: €804.3m. The latest transaction was reported on 3 October 2023 (Other). Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Pharmanutra PR has made its first sales in the US market, marking an important milestone in its international expansion. The company specializes in the development of innovative pharmaceutical products.